Published in Chest on March 01, 2001
Retracted Antenatal steroid therapy for fetal lung maturation and the subsequent risk of childhood asthma: a longitudinal analysis. J Pregnancy (2010) 1.46
A systematic review of asthma and health literacy: a cultural-ethnic perspective in Canada. MedGenMed (2007) 1.18
Agreement between aggregate and individual-level measures of income and education: a comparison across three patient groups. BMC Health Serv Res (2011) 0.90
Prevalence and predictors of tobacco treatment in an academic medical center. Jt Comm J Qual Patient Saf (2009) 0.86
Case-control study of residential radon and lung cancer in Winnipeg, Manitoba, Canada. Am J Epidemiol (1994) 4.32
The spatial association between community air pollution and mortality: a new method of analyzing correlated geographic cohort data. Environ Health Perspect (2001) 4.20
Effects of low ambient levels of ozone and sulfates on the frequency of respiratory admissions to Ontario hospitals. Environ Res (1994) 4.19
Association between particulate- and gas-phase components of urban air pollution and daily mortality in eight Canadian cities. Inhal Toxicol (2000) 2.88
Association between ambient carbon monoxide levels and hospitalizations for congestive heart failure in the elderly in 10 Canadian cities. Epidemiology (1997) 2.46
First analysis of cancer incidence and occupational radiation exposure based on the National Dose Registry of Canada. Am J Epidemiol (2001) 2.44
Associations between ambient particulate sulfate and admissions to Ontario hospitals for cardiac and respiratory diseases. Am J Epidemiol (1995) 2.40
Radon, cigarette smoke, and lung cancer: a re-analysis of the Colorado Plateau uranium miners' data. Epidemiology (1993) 2.35
The role of particulate size and chemistry in the association between summertime ambient air pollution and hospitalization for cardiorespiratory diseases. Environ Health Perspect (1997) 2.31
Increased effects of smoking and obesity on asthma among female Canadians: the National Population Health Survey, 1994-1995. Am J Epidemiol (1999) 2.13
Links between passive smoking and disease: a best-evidence synthesis. A report of the Working Group on Passive Smoking. Clin Invest Med (1990) 1.87
Childhood asthma and the indoor environment. Chest (1991) 1.85
Effect of short-term exposure to gaseous pollution on asthma hospitalisation in children: a bi-directional case-crossover analysis. J Epidemiol Community Health (2003) 1.82
The association between ambient carbon monoxide levels and daily mortality in Toronto, Canada. J Air Waste Manag Assoc (1998) 1.70
Association between ozone and hospitalization for respiratory diseases in 16 Canadian cities. Environ Res (1997) 1.66
Association between ozone and hospitalization for acute respiratory diseases in children less than 2 years of age. Am J Epidemiol (2001) 1.62
Epidemiology of pancreatic cancer: an overview. Cancer Detect Prev (2003) 1.54
Neonatal mortality and morbidity in vertex-vertex second twins according to mode of delivery and birth weight. J Perinatol (2006) 1.52
Risk of brain tumours in relation to estimated RF dose from mobile phones: results from five Interphone countries. Occup Environ Med (2011) 1.43
First analysis of mortality and occupational radiation exposure based on the National Dose Registry of Canada. Am J Epidemiol (1998) 1.29
Associations between cigarette smoking and each of 21 types of cancer: a multi-site case-control study. Int J Epidemiol (1995) 1.12
Cancer risk due to occupational exposure to polycyclic aromatic hydrocarbons. Am J Ind Med (1995) 1.11
Subjective fears and objective data: an epidemiologic study of environmental health concerns. Trans Assoc Am Physicians (1987) 1.07
Procedures for calculating benchmark doses for health risk assessment. Regul Toxicol Pharmacol (1998) 1.06
Specific fatty acid intake and the risk of pancreatic cancer in Canada. Br J Cancer (2005) 1.04
Statistical methods in cancer research. Volume III--The design and analysis of long-term animal experiments. IARC Sci Publ (1986) 1.01
On the use of historical control data to estimate dose response trends in quantal bioassay. Biometrics (1992) 0.97
A case-control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detect Prev (2000) 0.97
Determinants of mobile phone output power in a multinational study: implications for exposure assessment. Occup Environ Med (2009) 0.96
Dental amalgam and multiple sclerosis: a case-control study in Montreal, Canada. Int J Epidemiol (1998) 0.95
Indoor air quality risk factors for severe lower respiratory tract infections in Inuit infants in Baffin Region, Nunavut: a pilot study. Indoor Air (2006) 0.94
Case-control study of radon and lung cancer in New Jersey. Radiat Prot Dosimetry (2007) 0.93
Adjusting for measurement error in the Cox proportional hazards regression model. J Cancer Epidemiol Prev (2002) 0.93
Relationship between asthma prevalence and income among Canadians. JAMA (2001) 0.93
Particulate air pollution standards and morbidity and mortality: case study. Am J Epidemiol (2001) 0.93
Leisure-time energy expenditure in asthmatics and non-asthmatics. Respir Med (2001) 0.90
Methods for detecting and estimating population threshold concentrations for air pollution-related mortality with exposure measurement error. Risk Anal (1999) 0.89
Injury surveillance in Trinidad: an accident and emergency based injury surveillance system at the San Fernando General Hospital. West Indian Med J (2009) 0.89
A carcinogenicity study of commercial saccharin in the rat. Toxicol Appl Pharmacol (1975) 0.89
Is outdoor air pollution associated with physician visits for allergic rhinitis among the elderly in Toronto, Canada? Allergy (2006) 0.88
A comparison of statistical methods for low dose extrapolation utilizing time-to-tumor data. Fundam Appl Toxicol (1983) 0.88
Evaluation of regression calibration and SIMEX methods in logistic regression when one of the predictors is subject to additive measurement error. J Epidemiol Biostat (1999) 0.88
Associations between several sites of cancer and occupational exposure to benzene, toluene, xylene, and styrene: results of a case-control study in Montreal. Am J Ind Med (1998) 0.87
Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population. J Perinatol (2008) 0.87
Statistical issues in the analysis of the long-term carcinogenicity bioassay in small rodents: an empirical evaluation of statistical decision rules. Fundam Appl Toxicol (1989) 0.85
Carcinogenic risk assessment: a guide to the literature. Biometrics (1981) 0.85
Determining "safe" levels of exposure: safety factors or mathematical models? Fundam Appl Toxicol (1984) 0.83
A unified approach to risk assessment for cancer and noncancer endpoints based on benchmark doses and uncertainty/safety factors. Regul Toxicol Pharmacol (1999) 0.83
Adjusting for temporal variation in the analysis of parallel time series of health and environmental variables. J Expo Anal Environ Epidemiol (1998) 0.83
Recent bioassay results on coal tars and benzo(a)pyrene: implications for risk assessment. Regul Toxicol Pharmacol (1998) 0.83
Saccharin: a toxicological and historical perspective. Toxicology (1983) 0.82
Are the apparent effects of cigarette smoking on lung and bladder cancers due to uncontrolled confounding by occupational exposures? Epidemiology (1994) 0.82
Uncertainty and variability analysis in multiplicative risk models. Risk Anal (1998) 0.82
Sex-related interactive effect of smoking and household pets on asthma incidence. Eur Respir J (2002) 0.82
Cohort cancer incidence among pulp and paper mill workers in British Columbia. Scand J Work Environ Health (2001) 0.81
Mechanisms of carcinogenesis and biologically based models for estimation and prediction of risk. IARC Sci Publ (1999) 0.81
Cohort mortality study of pulp and paper mill workers in British Columbia, Canada. Am J Epidemiol (1997) 0.81
Tests for trend in developmental toxicity experiments with correlated binary data. Risk Anal (1994) 0.80
Cancer risks due to occupational exposure to formaldehyde: results of a multi-site case-control study in Montreal. Int J Cancer (1989) 0.79
Ecology of fungi in human dwellings. J Med Vet Mycol (1992) 0.79
Physiological pharmacokinetics and cancer risk assessment. Cancer Lett (1993) 0.79
Use of generalized linear mixed models in analyzing mutant frequency data from the transgenic mouse assay. Environ Mol Mutagen (1998) 0.79
Estimates of the number of liver carcinogens in bioassays conducted by the National Toxicology Program. Risk Anal (1998) 0.79
Air pollution exposures and children's health. Can J Public Health (1998) 0.78
An exact representation for the generating function for the Moolgavkar-Venzon-Knudson two-stage model of carcinogenesis with stochastic stem cell growth. Math Biosci (1996) 0.77
Statistical analysis of lacZ mutant frequency data from MutaMouse mutagenicity assays. Mutagenesis (1998) 0.77
Comments on "Children's health, susceptibility, and regulatory approaches to reducing risk from chemical carcinogens". Environ Health Perspect (2001) 0.77
Is there a safe level of exposure to a carcinogen? Environ Sci Technol (1995) 0.77
Cancer risk assessment with intermittent exposure. Risk Anal (1992) 0.77
The future of mechanistic research in risk assessment: where are we going and can we get there from here? Toxicology (1995) 0.76
Risk-based decision-making for blood safety: preliminary report of a consensus conference. Vox Sang (2011) 0.76
Pharmacokinetics of methylmercury in the blood of monkeys (Macaca fascicularis). Fundam Appl Toxicol (1989) 0.76
Interspecies extrapolation of toxicity data. Risk Anal (1992) 0.76
International case studies of psychosocial ripple effects of bovine spongiform encephalopathy (BSE) in European countries. J Toxicol Environ Health A (2009) 0.76
International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper No. 3. The concept of negativity in experimental carcinogenesis. Mutat Res (1986) 0.75
Estimates of the proportion of chemicals that were carcinogenic or anticarcinogenic in bioassays conducted by the National Toxicology Program. Environ Health Perspect (1999) 0.75
Overview, conclusions, and recommendations of the IPCS collaborative study on complex mixtures. Mutat Res (1992) 0.75
Biologically based risk assessment model for cyclophosphamide hematotoxicity in animal species: concluding comments. J Toxicol Environ Health A (2000) 0.75
Survey of public perceptions of prion disease risks in Canada: what does the public care about? J Toxicol Environ Health A (2009) 0.75
Empirical and biologically based models for cancer risk assessment. Drug Metab Rev (1996) 0.75
A comparison of methods for estimating the benchmark dose based on overdispersed data from developmental toxicity studies. Risk Anal (1998) 0.75
Interaction between two carcinogens in the two-stage clonal expansion model of carcinogenesis. J Epidemiol Biostat (2001) 0.75
Carcinogenic risk assessment with time-dependent exposure patterns. Risk Anal (1988) 0.75
A unified approach to risk characterization. Inhal Toxicol (2000) 0.75
Estimates of the proportions of carcinogens and anticarcinogens in bioassays conducted by the U.S. National Toxicology Program. Application of a new meta-analytic approach. Ann N Y Acad Sci (1999) 0.75
AMESFIT: a microcomputer program for fitting linear-exponential dose-response models in the Ames Salmonella assay. Environ Mol Mutagen (1993) 0.75
Strategies for clean air and health. J Toxicol Environ Health A (2007) 0.75
Environmental health risk assessment: hexachlorobenzene. IARC Sci Publ (1986) 0.75
Two stage model for carcinogenesis: number and size distributions of premalignant clones in longitudinal studies. Math Biosci (1999) 0.75
Long-term toxicity of hexachlorobenzene. Food Chem Toxicol (1988) 0.75
A Weibull model for the estimation of tumorigenic potency. Biometrics (1993) 0.75
Projection of residential radon lung cancer risks: the Beir VI risk models. Radiat Prot Dosimetry (2002) 0.75
Future perspectives, unresolved issues and research needs. IARC Sci Publ (1999) 0.75
Long- and medium-term carcinogenicity studies in animals and short-term genotoxicity tests. IARC Sci Publ (1999) 0.75
Additive and multiplicative relative risk in the two-stage clonal expansion model of carcinogenesis. Risk Anal (1991) 0.75